Validation of the Cheetah NICOM by Comparison to TEE During Open Vascular Surgery - Pilot Study

December 10, 2015 updated by: Louis-Philippe Fortier, Maisonneuve-Rosemont Hospital
The Cheetah NICOM is a non-invasive cardiac output monitor that has been validated in various clinical contexts but not during the occlusion of major arteries, as takes place in vascular surgery. The present study will evaluate the precision and validity of the measures taken by the device during open vascular surgery procedures. The measurements will be compared to the those calculated by transesophageal echocardiography at various key points during the surgeries. The validity of the cardiac output, stroke volume and stroke volume variation measurements will be evaluated, as well as the device's ability to track rapid changes in cardiac output.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Eric Peters
  • Phone Number: 514-252-3400

Study Contact Backup

  • Name: Nadia Godin, RN
  • Phone Number: 3193 514-252-3400

Study Locations

    • Quebec
      • Montréal, Quebec, Canada, H1T 2M4
        • Recruiting
        • Maisonneuve-Rosemont Hospital
        • Contact:
        • Principal Investigator:
          • Louis-Philippe Fortier, MSc,MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients undergoing either an open aortic aneurysm repair surgery or a femoral endarterectomy under general anesthesia.

Description

Inclusion Criteria:

  • Patient undergoing an elective open aortic aneurysm repair surgery or a femoral endarterectomy under general anesthesia.
  • ASA 1-3

Exclusion Criteria:

  • Refuses general anesthesia
  • Contraindication to transesophageal echocardiography
  • Allergy to the glue of the Cheetah NICOM probes
  • Severe aortic valve regurgitation
  • Thoracic aorta anatomy anomaly
  • Unipolar pacemaker

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Aortic Aneurysm Repair
The impact of large abdominal retractors and an abdominal aortic cross-clamp on the validity of the Cheetah NICOM's measurements will be evaluated in this group.
The Cheetah NICOM will be installed on all patients to evaluate the validity of its measurements.
TEE will serve as gold standard measurements for the evaluation of the Cheetah NICOM.
Femoral Endarterectomy
The impact of the clamping of a large peripheral arterial vessel on the validity of the Cheetah NICOM's measurements will be evaluated in this group.
The Cheetah NICOM will be installed on all patients to evaluate the validity of its measurements.
TEE will serve as gold standard measurements for the evaluation of the Cheetah NICOM.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Validity of Stroke Volume (SV) Measurements by the Cheetah NICOM
Time Frame: Per vascular surgery procedure
The SV measured by the Cheetah NICOM will be compared to the one measured by transesophageal echocardiography at multiple time points during the surgery.
Per vascular surgery procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stroke Volume (SV) with a vascular cross-clamp
Time Frame: Per vascular surgery procedure when a cross-clamp is installed
The SV measured by the Cheetah NICOM will be compared to the one measured by transesophageal echocardiography at multiple points once a vascular cross-clamp is installed.
Per vascular surgery procedure when a cross-clamp is installed
Stroke Volume (SV) trending ability
Time Frame: Per vascular surgery procedure
Between each pair of consecutive data points, the change of SV measurements given by the Cheetah NICOM will be compared to those given by transesophageal echocardiography.
Per vascular surgery procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Louis-Philippe Fortier, MD, MSc, Maisonneuve-Rosemont Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2015

Primary Completion (ANTICIPATED)

October 1, 2016

Study Registration Dates

First Submitted

December 2, 2015

First Submitted That Met QC Criteria

December 10, 2015

First Posted (ESTIMATE)

December 15, 2015

Study Record Updates

Last Update Posted (ESTIMATE)

December 15, 2015

Last Update Submitted That Met QC Criteria

December 10, 2015

Last Verified

December 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Peripheral Arterial Disease

Clinical Trials on Cheetah NICOM

3
Subscribe